| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Werewolf Therapeutics Inc (NASDAQ: HOWL)
HOWL Technical Analysis
4
| As on 12th Dec 2025 HOWL STOCK Price closed @ 1.10 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.33 & Strong Sell for SHORT-TERM with Stoploss of 1.53 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HOWLSTOCK Price
| Open | 1.10 | Change | Price | % |
| High | 1.10 | 1 Day | 0.01 | 0.92 |
| Low | 1.06 | 1 Week | 0.18 | 19.57 |
| Close | 1.10 | 1 Month | -0.30 | -21.43 |
| Volume | 367867 | 1 Year | -0.90 | -45.00 |
| 52 Week High 2.19 | 52 Week Low 0.63 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| OCG | 0.22 | -75.82% |
| NVDA | 175.02 | -3.27% |
| CGC | 1.74 | 53.98% |
| LMDX | 0.02 | 0.00% |
| PLUG | 2.32 | -1.69% |
| YGMZ | 0.02 | -66.67% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| HOWL Daily Charts |
HOWL Intraday Charts |
Whats New @ Bazaartrend |
HOWL Free Analysis |
|
|
HOWL Important Levels Intraday
| RESISTANCE | 1.18 |
| RESISTANCE | 1.15 |
| RESISTANCE | 1.14 |
| RESISTANCE | 1.12 |
| SUPPORT | 1.08 |
| SUPPORT | 1.06 |
| SUPPORT | 1.05 |
| SUPPORT | 1.02 |
HOWL Forecast December 2025
| 4th UP Forecast | 1.99 |
| 3rd UP Forecast | 1.7 |
| 2nd UP Forecast | 1.53 |
| 1st UP Forecast | 1.35 |
| 1st DOWN Forecast | 0.85 |
| 2nd DOWN Forecast | 0.67 |
| 3rd DOWN Forecast | 0.5 |
| 4th DOWN Forecast | 0.21 |
HOWL Weekly Forecast
| 4th UP Forecast | 1.70 |
| 3rd UP Forecast | 1.51 |
| 2nd UP Forecast | 1.39 |
| 1st UP Forecast | 1.27 |
| 1st DOWN Forecast | 0.93 |
| 2nd DOWN Forecast | 0.81 |
| 3rd DOWN Forecast | 0.69 |
| 4th DOWN Forecast | 0.50 |
HOWL Forecast2025
| 4th UP Forecast | 4.53 |
| 3rd UP Forecast | 3.43 |
| 2nd UP Forecast | 2.75 |
| 1st UP Forecast | 2.07 |
| 1st DOWN Forecast | 0.13 |
| 2nd DOWN Forecast | -0.55 |
| 3rd DOWN Forecast | -1.23 |
| 4th DOWN Forecast | -2.33 |
Werewolf Therapeutics Inc ( NASDAQ USA Symbol : HOWL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HOWL Business Profile
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, with the help of its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates include WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company also develops WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. Address: 1030 Massachusetts Avenue, Cambridge, MA, United States, 02138
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service